Glenmark Pharmaceuticals

Glenmark’s dermatology portfolio is built on scientific expertise, trusted therapies and improved access for patients with diverse skin conditions.

Glenmark supports Investigator Initiated Trials (IITs) to advance scientific research and explore new therapeutic possibilities.

Glenmark aims to improve health access and well-being in underserved communities through purpose-driven initiatives.

Glenmark’s innovation pipeline bridges cutting-edge science with real-world healthcare advancements through Ichnos Glenmark Innovation.

Glenmark and Ichnos Glenmark Innovation will showcase oncology research at ASCO 2026 in Chicago, USA, from May 29 to June 2.

Glenmark Malaysia emphasizes talent as a key asset, employing over 13,500 people from 60+ nationalities to drive its operations.

Glenmark offers global career opportunities in pharmaceuticals and invites applicants to join its talent community for future roles.

Glenmark develops branded, innovative, and generic medicines, focusing on respiratory, dermatology, and oncology therapies.

Know more about Board of Directors at Glenmark Pharmaceuticals

Know more about Glenmark’s global leadership team guiding the company’s strategy, innovation and growth.

Glenmark supports community well-being and health access through corporate social responsibility initiatives in underserved regions.

Glenmark employees can raise ethics or compliance concerns by speaking to their manager, another trusted manager, their HR representative, or the Compliance Officer.

Glenmark focuses its innovation on respiratory, dermatology, and oncology therapies to address unmet medical needs and deliver patient benefits.

Glenmark is a research-led pharmaceutical company focused on innovative, accessible therapies to improve global patient care.